MedTrace Logo

Pharmacokinetic Study of Topical Phenylephrine

NCT07033845 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-10-03

No results posted yet for this study

Summary

Pharmacokinetic Study of Topical Phenylephrine

Conditions

  • Chemotherapy Induced Alopecia
  • Chemotherapy Side Effects

Interventions

DEVICE

Phenylephrine

Topical Phenylephrine

Sponsors & Collaborators

  • Daniel Alain, Inc.

    collaborator UNKNOWN

  • Follea International Limited

    collaborator INDUSTRY

  • Applied Biology, Inc.

    lead INDUSTRY

Principal Investigators

  • Andy Goren, MD · University of Rome G. Marconi

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2025-10-19
Completion
2025-12-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07033845 on ClinicalTrials.gov